According to an article from the New York Times,

A Food and Drug Administration advisory panel on April 19, 2018 unanimously recommended approval of an epilepsy medication made with an ingredient found in marijuana. If the agency follows the recommendation, as is expected, the drug would be the first cannabis-derived prescription medicine available in the United States.

https://www.nytimes.com/2018/04/19/health/epidiolex-fda-cannabis-marajuana.html